2021
DOI: 10.3389/fchem.2021.677621
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients

Abstract: Diabetes has become a major public health concern worldwide, most of which are type 2 diabetes (T2D). The diagnosis of T2D is commonly based on plasma glucose levels, and there are no reliable clinical biomarkers available for early detection. Recent advances in proteome technologies offer new opportunity for the understanding of T2D; however, the underlying proteomic characteristics of T2D have not been thoroughly investigated yet. Here, using proteomic and glycoproteomic profiling, we provided a comprehensiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 53 publications
0
8
0
Order By: Relevance
“…Moreover, multiple serine proteases of the coagulation system have been shown to function as alternative activators of C5 and C3 of the complement cascade, 58 which was observed to be significantly elevated in other proteomic analyses of plasma from patients with T2D. 59 , 60 These pathways were strongly upregulated in PD of pancreatic islets, and the latter was also upregulated in liver of PD ( Figures 3 , 6 , and 7 ).…”
Section: Discussionmentioning
confidence: 95%
“…Moreover, multiple serine proteases of the coagulation system have been shown to function as alternative activators of C5 and C3 of the complement cascade, 58 which was observed to be significantly elevated in other proteomic analyses of plasma from patients with T2D. 59 , 60 These pathways were strongly upregulated in PD of pancreatic islets, and the latter was also upregulated in liver of PD ( Figures 3 , 6 , and 7 ).…”
Section: Discussionmentioning
confidence: 95%
“…The AP can be triggered by the direct recognition of certain microbial surface structures [ 7 , 56 ], and AP-regulating proteins, including Bf [ 57 ], Df [ 58 ], and complement P factor [ 59 ], tightly control this pathway. Df, a member of the chymotrypsin family of serine proteases, plays a pivotal role in both initiation and amplification loops of complement system activation by continuously promoting C3 cleavage in the AP [ 60 , 61 ]. It has been reported in many human and mouse disease models that the deficiency or dysfunction of Df weakens the host immune killing ability to foreign pathogens, including viruses and bacteria [ 8 , 27 , 28 , 29 , 62 , 63 ].…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently, activity of this C3 convertase leads to the cleavage of C3 and the activation of terminal complement components and to the formation of a membrane attack complex that eliminates invading microbes or host cells infected with viruses [ 10 , 74 ]. In addition, Df is a component absolutely required for the AP, since it is the only enzyme in mammalian blood able to catalyze C3bBb formation [ 61 , 62 , 75 ]. Therefore, Df plays an important role in the complement system against invading pathogens and is considered a vital target for the pharmaceutical control of complement activation.…”
Section: Discussionmentioning
confidence: 99%
“…To maintain consistent data quality, each assay incorporated a 1 μg sample of the peptide mixture, undergoing a 78 min gradient separation. Specifics of the gradient and MS parameters can be found in our earlier publication [ 22 ]. Over a span of 8 months, our team successfully generated a total of 308 raw MS files for QC in HeLa proteomics analysis.…”
Section: Methodsmentioning
confidence: 99%